i am taking medical officer exam in bharatpur hospital tomorrow create suubject wise high ueild points and qucik reviosn note as per the past question pattern in medical officer exam of nepal
Nepal medical officer exam Bharatpur hospital past questions pattern syllabus 2024 2025
Nepal loksewa medical officer exam high yield topics MCQ pattern internal medicine surgery gynecology
Nepal medical officer exam syllabus high yield topics MCQ pattern
Nepal hospital service commission medical officer MCQ repeated questions internal medicine pharmacology community medicine 2023 2024
| Topic | Key Points |
|---|---|
| MI | STEMI: ST elevation + new LBBB. First drug = Aspirin 300mg. Thrombolysis within 12 hrs. Best reperfusion = PCI within 90 min |
| Heart Failure | BNP elevated. LVEF <40% = systolic HF. ACE inhibitor + beta blocker + diuretic = standard |
| Atrial Fibrillation | Irregularly irregular. Rate control: digoxin/beta blocker. Rhythm control: amiodarone. CHADS₂ score for anticoagulation |
| Rheumatic Fever | Jones Criteria: 2 major OR 1 major + 2 minor. Major = carditis, polyarthritis, Sydenham's chorea, erythema marginatum, subcutaneous nodules |
| Endocarditis | Duke criteria. S. viridans = most common in native valve. S. aureus = most common overall/IV drug users. HACEK organisms = culture negative |
| Hypertension | JNC: Stage 2 = ≥140/90. Hypertensive crisis >180/120. First line = ACE inhibitor/ARB for DM/CKD; thiazide for isolated systolic |
| Topic | Key Points |
|---|---|
| TB | 2HRZE/4HR. AFB +ve → start treatment. Miliary TB: snowstorm on CXR. Cat I (new): 2HRZE + 4HR. DOTS mandatory in Nepal |
| Pneumonia | CAP: amoxicillin first line. CURB-65 score. Atypical: Mycoplasma (bilateral infiltrates, cold agglutinins) |
| COPD | FEV₁/FVC <0.7 post-bronchodilator. GOLD staging. SABA for acute; LAMA + LABA for maintenance. O₂ target 88-92% |
| Asthma | Reversible obstruction. Peak flow >20% variation. Step-up: SABA → ICS → LABA → oral steroid |
| Pleural Effusion | Exudate: Light's criteria (LDH ratio >0.6, protein ratio >0.5). Transudate: CHF, cirrhosis, nephrotic |
| Topic | Key Points |
|---|---|
| DM | Diagnosis: FBS ≥7 mmol/L or RBS ≥11.1 or HbA1c ≥6.5%. Type 1: insulin. Type 2: metformin first line |
| DKA | pH <7.3, bicarbonate <15, ketones. Management: IV fluids → insulin → K⁺ replacement |
| Thyroid | Hypothyroid: T4↓, TSH↑. Hyperthyroid: T4↑, TSH↓. Graves = TSH receptor antibody (TRAb). Levothyroxine for hypothyroid |
| Cushing's | Moon face, buffalo hump, purple striae, hypertension. 24-hr urine cortisol = best screening |
| Addison's | Hyperpigmentation, hypotension, hyponatremia, hyperkalemia. ACTH stimulation test |
| Topic | Key Points |
|---|---|
| Stroke | Ischemic (80%): rt-PA within 4.5 hrs (NIHSS). Hemorrhagic: BP control. FAST acronym |
| Meningitis | Bacterial: LP (↑protein, ↓glucose, PMN). Empirical: ceftriaxone + dexamethasone. TB meningitis: lymphocytes |
| Epilepsy | First line: carbamazepine (partial), valproate (generalized). Status epilepticus: IV diazepam → phenytoin |
| Parkinson's | Tremor (pill-rolling), rigidity, bradykinesia, postural instability. Levodopa + carbidopa = gold standard |
| Topic | Key Points |
|---|---|
| Anemia | Iron deficiency: MCV↓, serum ferritin↓, TIBC↑. B12 deficiency: megaloblastic, subacute combined degeneration |
| ITP | Isolated thrombocytopenia, normal bone marrow. First line: prednisolone. IVIg for bleeding/surgery |
| CML | Philadelphia chromosome t(9;22), BCR-ABL. Imatinib (tyrosine kinase inhibitor) = treatment |
| Sickle Cell | HbS. Vaso-occlusive crisis: pain, dactylitis, acute chest. Hydroxyurea reduces crises |
| Topic | Key Points |
|---|---|
| Typhoid | Widal test (1:160 diagnostic). Bone marrow culture = gold standard. Treatment: ciprofloxacin or azithromycin. Rose spots on abdomen |
| Malaria | P. falciparum = most dangerous (cerebral malaria). RDT + blood smear. Chloroquine for P. vivax; artemisinin-based for P. falciparum |
| Dengue | NS1 antigen (days 1-5), IgM/IgG (after day 5). Dengue hemorrhagic fever: platelet <100,000 + plasma leakage. No aspirin/NSAIDs |
| Kala-azar | Visceral leishmaniasis, endemic in Terai. Splenomegaly, pancytopenia, fever. Treatment: miltefosine (oral) or liposomal amphotericin B |
| Leptospirosis | Weil's disease: jaundice + AKI + hemorrhage. Treatment: doxycycline (mild), penicillin G (severe) |
| Vaccine | Age | Dose | Route |
|---|---|---|---|
| BCG | Birth | 0.1 mL | Intradermal |
| OPV | 6, 10, 14 weeks + 9 months | 2 drops | Oral |
| Pentavalent (DPT-HepB-Hib) | 6, 10, 14 weeks | 0.5 mL | IM |
| PCV | 6, 10, 14 weeks | 0.5 mL | IM |
| MR (Measles-Rubella) | 9 months + 15 months | 0.5 mL | SC |
| JE | 12 months | 0.5 mL | SC |
| Td | 10 years, 16 years | 0.5 mL | IM |
| Topic | Key Points |
|---|---|
| Preeclampsia | BP ≥140/90 after 20 weeks + proteinuria. Severe: ≥160/110 or end organ damage. MgSO₄ for seizure prophylaxis. Delivery = definitive |
| Eclampsia | Seizures + hypertension in pregnancy. MgSO₄ (loading 4g IV + 10g IM, then 5g IM 4 hrly) |
| APH | Placenta previa (painless bleeding, placenta covers os, C-section) vs Abruptio placentae (painful, tender uterus, may have concealed bleed) |
| PPH | >500 mL blood loss after vaginal delivery. 4 T's: Tone (80%), Tissue, Trauma, Thrombin. Oxytocin = first line. Carboprost, B-Lynch suture |
| Ectopic | Most common in ampulla. Pain + amenorrhea + vaginal bleeding. β-hCG + TVS. Methotrexate (unruptured) or surgery |
| Gestational DM | Screen at 24-28 weeks. OGTT. Insulin = preferred treatment |
| PROM | Membranes rupture before labor. Preterm PROM <37 weeks: corticosteroids + antibiotics + tocolysis |
| Topic | Key Points |
|---|---|
| Cervical Cancer | Most common gynecological cancer in Nepal. HPV 16, 18. Pap smear screening. Stage I: surgery; Stage II+: radiotherapy + cisplatin |
| Endometrial Cancer | Post-menopausal bleeding = cancer until proven otherwise. Associated with unopposed estrogen, obesity, PCOS |
| PCOS | Rotterdam criteria: 2 of 3 (oligo/anovulation, hyperandrogenism, PCO on USS). Metformin + clomiphene for ovulation |
| Fibroid | Most common benign uterine tumor. Menorrhagia, pressure symptoms. Myomectomy (fertility-preserving) vs hysterectomy |
| Contraception | IUCD: most effective LARC. Progestin-only pill: for BF mothers. Emergency: levonorgestrel within 72 hrs or copper IUCD within 5 days |
| Topic | Key Points |
|---|---|
| Appendicitis | RIF pain, Rovsing's sign, rebound tenderness. Alvarado score ≥7 = surgery. Perforation → peritonitis |
| Intestinal Obstruction | Small bowel: colicky pain, distension, vomiting early, constipation late. X-ray: air-fluid levels, step-ladder pattern |
| Peptic Ulcer | H. pylori → triple therapy (omeprazole + amoxicillin + clarithromycin × 7-14 days). Perforation: free air under diaphragm on X-ray |
| Acute Abdomen | Assess: site of pain, guarding, rigidity. Investigations: USS, CT, erect CXR |
| Head Injury | GCS: 13-15 mild, 9-12 moderate, ≤8 severe. Extradural: lucid interval + biconvex hematoma (MMA rupture). Subdural: crescent-shaped, bridging veins |
| Burns | Rule of nines. Parkland formula: 4 mL/kg/% TBSA in 24 hrs (half in first 8 hrs with RL). >15% adult → IV fluids mandatory |
| Thyroid | Follicular carcinoma = hematogenous spread. Papillary = most common, lymphatic spread, best prognosis. Total thyroidectomy |
| Breast | FNAC for diagnosis. Mastectomy vs BCS + radiotherapy. Sentinel lymph node biopsy |
| Hernia | Inguinal (indirect most common overall, direct in elderly). Richter's: knuckle of bowel. Littre's: Meckel's diverticulum |
| Topic | Key Points |
|---|---|
| IMCI danger signs | Cannot drink, persistent vomiting, convulsions, lethargy, stridor at rest, severe malnutrition |
| Pneumonia | Fast breathing: <2 months ≥60/min; 2-12 months ≥50/min; 1-5 years ≥40/min. Amoxicillin for non-severe CAP |
| Meningitis | Full fontanelle, stiff neck (not in neonates). Empirical: ceftriaxone + dexamethasone |
| Diarrhea | ORS for dehydration. Severe dehydration: Ringer's Lactate 100 mL/kg (3-4 hours for children). Zinc 20 mg/day × 14 days |
| Malnutrition (SAM) | MUAC <11.5 cm or WHZ <-3. F-75 (stabilization) → F-100 (rehabilitation) |
| Neonatal Jaundice | Physiological: day 2-7, bilirubin <15 mg/dL. Pathological: day 1 or >15. Phototherapy; exchange transfusion if severe |
| Kawasaki | Fever >5 days + 4 of: conjunctivitis, mucositis, rash, cervical LN, limb changes. Coronary artery aneurysm = complication. Aspirin + IVIG |
| Development | Social smile: 6 weeks; Sits unsupported: 6 months; Walks: 12 months; 2-word sentences: 24 months |
| Drug | Key Point |
|---|---|
| Aspirin | Irreversibly inhibits COX. Tinnitus = toxicity. Reye's syndrome in children |
| Metformin | Biguanide, decreases hepatic gluconeogenesis. Lactic acidosis = contraindication in renal failure (eGFR <30) |
| Warfarin | Vitamin K antagonist. Antidote = Vitamin K (slow) or FFP (fast). INR monitoring. Teratogenic |
| Heparin | UFH: antidote = protamine sulfate. LMWH: enoxaparin. Heparin-induced thrombocytopenia (HIT) = platelet drop >50% |
| Morphine | Antidote = naloxone. Avoid in head injury (raises ICP), asthma, renal failure |
| Amiodarone | Side effects: pulmonary fibrosis, hypo/hyperthyroidism, corneal deposits, hepatotoxicity, photosensitivity |
| Gentamicin | Aminoglycoside: ototoxicity + nephrotoxicity. Trough level monitoring |
| Chloramphenicol | Grey baby syndrome (neonates). Aplastic anemia |
| Tetracycline | Avoid in pregnancy and children <8 yrs (teeth staining + bone growth). Take on empty stomach |
| SSRIs | First-line for depression. Serotonin syndrome: hyperthermia + rigidity + clonus |
| ORS Formula | NaCl 2.6g, KCl 1.5g, Na-citrate 2.9g, glucose 13.5g per litre |
| Topic | Key Points |
|---|---|
| Tonsillitis | Recurrent (≥3/year): tonsillectomy. Peritonsillar abscess: incision & drainage |
| CSOM | Safe type (tubotympanic): central perforation, no cholesteatoma. Unsafe type (atticoantral): attic/posterior perforation, cholesteatoma |
| Epistaxis | Little's area (anterior, Kiesselbach's plexus) = most common site. Treatment: anterior nasal packing. Posterior bleeding: Foley catheter/post-pack |
| Otitis Media | AOM: amoxicillin. Myringotomy for recurrent/effusion |
| Topic | Key Points |
|---|---|
| Trachoma | Chlamydia trachomatis. WHO grading: TF, TI, TS, TT, CO. Azithromycin single dose. SAFE strategy |
| Glaucoma | Chronic open-angle: elevated IOP >21 mmHg, cup-disc ratio >0.5, painless. Acute angle-closure: painful red eye, halos, nausea. Pilocarpine + acetazolamide |
| Cataract | Most common cause of blindness in Nepal. Phacoemulsification. Nuclear sclerosis = most common type |
| Diabetic Retinopathy | Background → preproliferative → proliferative. Neovascularization = proliferative. Laser photocoagulation |
| Conjunctivitis | Bacterial: purulent discharge. Viral: watery discharge. Allergic: itching. Neonatal gonococcal = emergency (1% silver nitrate prophylaxis) |
| Topic | Key Points |
|---|---|
| Rigor mortis | Starts 2-6 hrs, complete 12 hrs, disappears 36-48 hrs (begins in jaw/neck, descends) |
| Post-mortem lividity | Starts 1-2 hrs, fixed at 6-12 hrs |
| Adipocere | Saponification of body fat, occurs in moist conditions |
| Rape (Nepal law) | Age of consent = 20 years (for statutory rape). Hymen examination: not reliable indicator. Spermatozoa survive: 72 hrs in vagina |
| Wounds | Incised: sharp weapon, clean edges. Lacerated: blunt weapon, irregular edges. Contusion: closed injury |
| Infanticide | Hydrostatic test (lung floatation test) for live birth vs stillbirth |
| Nepal Medical Council Act | Prescribing rights, registration requirements, disciplinary proceedings |
| Abortion law in Nepal | Legal up to 12 weeks on request; up to 18 weeks if rape/incest; up to 28 weeks if fetal abnormality/maternal health |
| Act/Policy | Key Point |
|---|---|
| Nepal Health Service Act 2053 | Framework for health service personnel |
| Nepal Medical Council Act 2020 | Registration, licensing, disciplinary action |
| Safe Abortion Law (2002) | Conditions and limits above |
| Organ Transplant Act 2055 | Living related donors only (up to 4th degree relatives); brain death criteria |
| Breast Milk Substitute Act | Prohibits advertising of infant formula for children <2 years |
| National Health Policy 2019 | Universal Health Coverage; Primary Health Care focus |
| NHSSP | Nepal Health Sector Strategic Plan |
| MDR-TB | Resistance to isoniazid + rifampicin. Bedaquiline-based regimen |